statistiche ricercatore

Continente	#
NA - Nord America	491
AS - Asia	313
EU - Europa	262
SA - Sud America	62
AF - Africa	16
Continente sconosciuto - Info sul continente non disponibili	14
OC - Oceania	1
Totale	1.159

Nazione	#
US - Stati Uniti d'America	483
SG - Singapore	127
CN - Cina	74
IT - Italia	66
BR - Brasile	50
DE - Germania	41
HK - Hong Kong	39
FI - Finlandia	32
VN - Vietnam	23
UA - Ucraina	22
GB - Regno Unito	19
FR - Francia	17
RU - Federazione Russa	10
TR - Turchia	10
IE - Irlanda	9
GR - Grecia	7
IN - India	7
MK - Macedonia	7
AR - Argentina	5
CA - Canada	5
EG - Egitto	5
NL - Olanda	5
PL - Polonia	5
SA - Arabia Saudita	5
ZA - Sudafrica	5
AT - Austria	4
CZ - Repubblica Ceca	4
IQ - Iraq	4
EC - Ecuador	3
MX - Messico	3
SE - Svezia	3
BD - Bangladesh	2
BE - Belgio	2
ES - Italia	2
GE - Georgia	2
KZ - Kazakistan	2
LT - Lituania	2
MA - Marocco	2
PH - Filippine	2
PK - Pakistan	2
TW - Taiwan	2
VE - Venezuela	2
AL - Albania	1
AU - Australia	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BH - Bahrain	1
BJ - Benin	1
CH - Svizzera	1
CI - Costa d'Avorio	1
CO - Colombia	1
DZ - Algeria	1
ID - Indonesia	1
JO - Giordania	1
JP - Giappone	1
LB - Libano	1
LU - Lussemburgo	1
LV - Lettonia	1
MY - Malesia	1
PS - Palestinian Territory	1
PY - Paraguay	1
SY - Repubblica araba siriana	1
TH - Thailandia	1
TM - Turkmenistan	1
UG - Uganda	1
UZ - Uzbekistan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.146

Nome	#
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study	216
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic	126
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies	122
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study	116
Safety considerations when using drugs in pregnant patients with systemic lupus erythematosus	116
Obstetric Anti-phospholipid Syndrome: State of the Art	115
Variations of C3 and C4 Before and During Pregnancy in Systemic Lupus Erythematosus: Association With Disease Flares and Obstetric Outcomes	104
The Course of Rheumatic Diseases During Pregnancy	95
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis	78
Management of maternal antiphospholipid syndrome	71
Totale	1.159

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	88	0	13	10	4	1	5	2	7	5	10	16	15
2022/2023	44	12	0	2	0	7	12	1	3	5	0	2	0
2023/2024	112	10	2	11	9	3	20	4	5	23	10	3	12
2024/2025	239	4	5	5	23	21	27	18	18	10	19	61	28
2025/2026	491	45	56	41	68	55	38	76	25	21	42	13	11
2026/2027	17	15	2	0	0	0	0	0	0	0	0	0	0
Totale													1.159